A phase I study of the safety and pharmacodynamic effects of everolimus in combination with lenalidomide in patients with advanced solid malignancies.

被引：0
|
作者：
Owonikoko, Taofeek Kunle
Harvey, R. Donald
Kauh, John S.
Lewis, Colleen Margaret
Hossain, Mohammed S.
Akintayo, Adebowale O.
Merriewether, A. Rene
Chen, Zhengjia
Hawk, Natalyn Nicole
Saba, Nabil F.
Harris, Wayne
Shin, Dong Moon
El-Rayes, Bassel F.
Huang, Chunzi
Lonial, Sagar
Lawson, David H.
Khuri, Fadlo Raja
Waller, Edmund K.
Ramalingam, Suresh S.
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Atlanta VA Med Ctr, Atlanta, GA USA
[3] Emory Univ, Atlanta, GA 30322 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2576
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma
    Harvey, R. Donald
    Carthon, Bradley C.
    Lewis, Colleen
    Hossain, Mohammad S.
    Zhang, Chao
    Chen, Zhengjia
    Harris, Wayne B.
    Alese, Olatunji B.
    Shaib, Walid
    Bilen, Mehmet A.
    Lawson, David H.
    Wu, Christina
    Steuer, Conor E.
    El-Rayes, Bassel F.
    Khuri, Fadlo R.
    Lonial, Sagar
    Waller, Edmund K.
    Ramalingam, Suresh S.
    Owonikoko, Taofeek K.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 123 (08) : 1228 - 1234
  • [2] Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma
    R. Donald Harvey
    Bradley C. Carthon
    Colleen Lewis
    Mohammad S. Hossain
    Chao Zhang
    Zhengjia Chen
    Wayne B. Harris
    Olatunji B. Alese
    Walid Shaib
    Mehmet A. Bilen
    David H. Lawson
    Christina Wu
    Conor E. Steuer
    Bassel F. El-Rayes
    Fadlo R. Khuri
    Sagar Lonial
    Edmund K. Waller
    Suresh S. Ramalingam
    Taofeek K. Owonikoko
    [J]. British Journal of Cancer, 2020, 123 : 1228 - 1234
  • [3] Phase I study of the combination of everolimus (RAD00l) with panitumumab in patients with refractory solid malignancies.
    Davies, J. M.
    Raftery, L. L.
    Sanoff, H. K.
    Triglianos, T.
    Keller, K.
    Ivanova, A.
    Bernard, S. A.
    Goldberg, R. M.
    Dees, E. C.
    O'Neil, B. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase I combination study of irofulven (IROF) and gemcitabine (GEM) in patients (pts) with advanced solid malignancies.
    O'Bryant, CL
    Gore, L
    Long, M
    Gustafson, D
    Eppers, S
    Basche, M
    Rothenberg, M
    Weems, G
    Shah, A
    Herdrich, L
    Eckhardt, SG
    Berlin, J
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9119S - 9120S
  • [5] Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
    Cascone, T.
    Sacks, R. L.
    Subbiah, I. M.
    Drobnitzky, N.
    Piha-Paul, S. A.
    Hong, D. S.
    Hess, K. R.
    Amini, B.
    Bhatt, T.
    Fu, S.
    Naing, A.
    Janku, F.
    Karp, D.
    Falchook, G. S.
    Conley, A. P.
    Sherman, S., I
    Meric-Bernstam, F.
    Ryan, A. J.
    Heymach, J., V
    Subbiah, V
    [J]. ESMO OPEN, 2021, 6 (02)
  • [6] Brequinar in combination with cisplatin in patients with advanced malignancies. A phase I study with pharmacokinetics
    Burris, A
    Raymond, E
    Awada, A
    Kuhn, J
    O'Rourke, J
    Brentzel, J
    Lynch, W
    King, SY
    Brown, T
    Von Hoff, D
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 125 - 125
  • [7] Phase I expansion study of sunitinib and bevacizumab in patients with advanced solid malignancies.
    Mittal, Kriti
    Koon, Henry B.
    Elson, Paul
    Triozzi, Pierre L.
    Dowlati, Afshin
    Borden, Ernest C.
    Rini, Brian I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Phase I study of trabectedin (T) in combination with docetaxel (D) in patients with advanced malignancies.
    Von Mehren, M.
    Buck, D.
    Temmer, E.
    Elsayed, Y. A.
    Cohen, R. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 96S - 96S
  • [9] Phase I combination study of trabectedin (T) and capecitabine (C) in patients with advanced malignancies.
    Gore, L.
    Rivera, E.
    Lavallee, K.
    Holden, S.
    Grolnic, S.
    Cleere, D.
    Moulder, S. L.
    Elsayed, Y. A.
    Eckhardt, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 98S - 98S
  • [10] Phase I trial of oral etoposide in combination with celecoxib in patients with advanced malignancies.
    Luu, TH
    Twardowski, P
    Leong, L
    Lim, D
    Morgan, R
    McNamara, M
    Portnow, J
    Ruel, C
    Shibata, S
    Synold, T
    Doroshow, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 241S - 241S
12345